Cranial Electrotherapy for Military Beneficiaries With Restless Legs Syndrome

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Restless Legs Syndrome
Interventions
DEVICE

Active CES Device Alpha-Stim®

The Alpha-Stim® device is a Class II FDA-approved device for the delivery of cranial electrotherapy using microcurrents that are delivered via two electrodes worn on the earlobes. Active CES devices will be pre-programmed by the manufacturer to deliver a bipolar, asymmetric rectangular waveform at a current of 100 µa, a level that is generally undetectable by the wearer of the device. At these settings, the manufacturer recommends a treatment duration of 60 minutes. Participants will not be able to alter the settings in any way.

DEVICE

Sham Device

The inactive (sham) devices look identical to the active device but are inactivated by the manufacturer so as not to deliver any electrical current.

Trial Locations (1)

96859-5000

Tripler Army Medical Center, Honolulu

All Listed Sponsors
collaborator

University of Virginia

OTHER

lead

Tripler Army Medical Center

FED

NCT02419014 - Cranial Electrotherapy for Military Beneficiaries With Restless Legs Syndrome | Biotech Hunter | Biotech Hunter